Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Randomized, inpatient, ascending multiple dose study given to subjects with schizophrenia and
schizoaffective disorder to assess safety and tolerability.